Assessment of Body Volume (total and regional) in Association with Metabolic Risk Factors for Heart Disease

Overview

About this study

The purpose of this study is to determine if your body volume (total and regional) is associated with metabolic risk factors for heart disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects will be recruited at the Cardiovascular Health Clinic, Mayo Clinic Rochester
Age: 18-70 yrs old
Both females and males

Exclusion Criteria:

Significant left ventricular dysfunction (EF< 30%)
Recent heart failure decompensation
End-stage liver or renal disease
Myxedema
Pregnant Women
Patients with implanted pacemaker or defibrillator
Patients with orthopedic metal implants
Cancer or expected survival < 2 years
Previous organ transplantation
Patients not giving authorization to use their medical record and blood samples for research.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Francisco Lopez-Jimenez, M.D.	Closed for enrollment	Contact information: Francisco Lopez Jimenez M.D. (507)284-8087 lopez@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Francisco Lopez-Jimenez, M.D.

Closed for enrollment

Contact information:

Francisco Lopez Jimenez M.D.

(507)284-8087

lopez@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials